Source:http://linkedlifedata.com/resource/pubmed/id/18455494
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2008-6-16
|
pubmed:abstractText |
Y459H and V492E mutations of cytochrome P450 reductase (CYPOR) cause Antley-Bixler syndrome due to diminished binding of the FAD cofactor. To address whether these mutations impaired the interaction with drug-metabolizing CYPs, a bacterial model of human liver expression of CYP1A2 and CYPOR was implemented. Four models were generated: POR(null), POR(wt), POR(YH), and POR(VE), for which equivalent CYP1A2 and CYPOR levels were confirmed, except for POR(null), not containing any CYPOR. The mutant CYPORs were unable to catalyze cytochrome c and MTT reduction, and were unable to support EROD and MROD activities. Activity was restored by the addition of FAD, with V492E having a higher apparent FAD affinity than Y459H. The CYP1A2-activated procarcinogens, 2-aminoanthracene, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, and 2-amino-3-methylimidazo(4,5-f)quinoline, were significantly less mutagenic in POR(YH) and POR(VE) models than in POR(wt), indicating that CYP1A2, and likely other drug-metabolizing CYPs, are impaired by ABS-related POR mutations as observed in the steroidogenic CYPs.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Cytochrome P-450 CYP1A2,
http://linkedlifedata.com/resource/pubmed/chemical/Flavin-Adenine Dinucleotide,
http://linkedlifedata.com/resource/pubmed/chemical/Formazans,
http://linkedlifedata.com/resource/pubmed/chemical/MTT formazan,
http://linkedlifedata.com/resource/pubmed/chemical/NADPH-Ferrihemoprotein Reductase,
http://linkedlifedata.com/resource/pubmed/chemical/Tetrazolium Salts,
http://linkedlifedata.com/resource/pubmed/chemical/Xenobiotics
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
1096-0384
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
15
|
pubmed:volume |
475
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
93-9
|
pubmed:meshHeading |
pubmed-meshheading:18455494-Catalysis,
pubmed-meshheading:18455494-Craniosynostoses,
pubmed-meshheading:18455494-Cytochrome P-450 CYP1A2,
pubmed-meshheading:18455494-Flavin-Adenine Dinucleotide,
pubmed-meshheading:18455494-Formazans,
pubmed-meshheading:18455494-Humans,
pubmed-meshheading:18455494-Mutation,
pubmed-meshheading:18455494-NADPH-Ferrihemoprotein Reductase,
pubmed-meshheading:18455494-Oxidation-Reduction,
pubmed-meshheading:18455494-Syndrome,
pubmed-meshheading:18455494-Tetrazolium Salts,
pubmed-meshheading:18455494-Xenobiotics
|
pubmed:year |
2008
|
pubmed:articleTitle |
Impairment of human CYP1A2-mediated xenobiotic metabolism by Antley-Bixler syndrome variants of cytochrome P450 oxidoreductase.
|
pubmed:affiliation |
Department of Genetics, Faculty of Medical Sciences, Universidade Nova de Lisboa, Rua da Junqueira 96, 1349-008 Lisbon, Portugal. mkranendonk.gene@fcm.unl.pt <mkranendonk.gene@fcm.unl.pt>
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|